Non-Invasive Cancer Diagnostics Market Report

Global and China Non-Invasive Cancer Diagnostics Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 11, 2022
  • PAGES：187
  • REPORT CODE：GMM1455116
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market.

    The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment.

    This report elaborates on the current development of the Non-Invasive Cancer Diagnostics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Cancer, Genetics Inc

    • BIOVIEW Inc

    • Quest Diagnostics Inc

    • Laboratory Corporation of America Holdings (LabCorp)

    • Affymetrix Inc

    • Precision Therapeutics

    • Gen-Probe Inc

    • Digene Corporation

    • AVIVA Biosciences Corporation

    • A&G Pharmaceutical

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • CTCs

    • CTNAS

    • Exosomes

    Application:

    • Blood

    • Urine

    • Saliva

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Non-Invasive Cancer Diagnostics Industry Overview

      • 1.1.1 Non-Invasive Cancer Diagnostics Market Scope and Market Segments

      • 1.1.2 Non-Invasive Cancer Diagnostics Industry Characteristics

      • 1.1.3 Global and China Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Non-Invasive Cancer Diagnostics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Non-Invasive Cancer Diagnostics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 CTCs

      • 1.2.2 CTNAS

      • 1.2.3 Exosomes

    • 1.3 Global Non-Invasive Cancer Diagnostics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Blood

      • 1.3.2 Urine

      • 1.3.3 Saliva

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Non-Invasive Cancer Diagnostics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Non-Invasive Cancer Diagnostics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Non-Invasive Cancer Diagnostics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Non-Invasive Cancer Diagnostics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Non-Invasive Cancer Diagnostics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Non-Invasive Cancer Diagnostics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Non-Invasive Cancer Diagnostics Industry PEST Analysis

    • 2.3 Non-Invasive Cancer Diagnostics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Non-Invasive Cancer Diagnostics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Non-Invasive Cancer Diagnostics Industry

    Chapter 3 Global and China Non-Invasive Cancer Diagnostics Market, by Manufacturer

    • 3.1 Global and China Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Non-Invasive Cancer Diagnostics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Non-Invasive Cancer Diagnostics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Non-Invasive Cancer Diagnostics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Non-Invasive Cancer Diagnostics Market Top 3 Players

    Chapter 4 Global and China Non-Invasive Cancer Diagnostics Market, by Type (2017-2028)

    • 4.1 Non-Invasive Cancer Diagnostics Market Trend, by Type

    • 4.2 Global Non-Invasive Cancer Diagnostics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Non-Invasive Cancer Diagnostics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Non-Invasive Cancer Diagnostics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Non-Invasive Cancer Diagnostics Price Trend, by Type (2017-2028)

    • 4.3 China Non-Invasive Cancer Diagnostics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Non-Invasive Cancer Diagnostics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Non-Invasive Cancer Diagnostics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Non-Invasive Cancer Diagnostics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Non-Invasive Cancer Diagnostics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Non-Invasive Cancer Diagnostics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Non-Invasive Cancer Diagnostics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Non-Invasive Cancer Diagnostics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Non-Invasive Cancer Diagnostics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Non-Invasive Cancer Diagnostics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Non-Invasive Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Non-Invasive Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Non-Invasive Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Non-Invasive Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Non-Invasive Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Non-Invasive Cancer Diagnostics Market Analysis

    • 7.1 North America Non-Invasive Cancer Diagnostics Market, by Type

    • 7.2 North America Non-Invasive Cancer Diagnostics Market, by Application

    • 7.3 North America Non-Invasive Cancer Diagnostics Market Analysis and Forecast, by Country

      • 7.3.1 United States Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Non-Invasive Cancer Diagnostics Market Analysis

    • 8.1 Europe Non-Invasive Cancer Diagnostics Market, by Type

    • 8.2 Europe Non-Invasive Cancer Diagnostics Market, by Application

    • 8.3 Europe Non-Invasive Cancer Diagnostics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Non-Invasive Cancer Diagnostics Market Analysis

    • 9.1 APAC Non-Invasive Cancer Diagnostics Market, by Type

    • 9.2 APAC Non-Invasive Cancer Diagnostics Market, by Application

    • 9.3 APAC Non-Invasive Cancer Diagnostics Market Analysis and Forecast, by Country

      • 9.3.1 China Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Non-Invasive Cancer Diagnostics Market Analysis

    • 10.1 Latin America, Middle East and Africa Non-Invasive Cancer Diagnostics Market, by Type

    • 10.2 Latin America, Middle East and Africa Non-Invasive Cancer Diagnostics Market, by Application

    • 10.3 Latin America, Middle East and Africa Non-Invasive Cancer Diagnostics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Non-Invasive Cancer Diagnostics Company Profiles

      • 11.1 Cancer, Genetics Inc

        • 11.1.1 Cancer, Genetics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product Profiles, Application and Specification

        • 11.1.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 BIOVIEW Inc

        • 11.2.1 BIOVIEW Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 BIOVIEW Inc Non-Invasive Cancer Diagnostics Product Profiles, Application and Specification

        • 11.2.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Quest Diagnostics Inc

        • 11.3.1 Quest Diagnostics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product Profiles, Application and Specification

        • 11.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Laboratory Corporation of America Holdings (LabCorp)

        • 11.4.1 Laboratory Corporation of America Holdings (LabCorp) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product Profiles, Application and Specification

        • 11.4.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Affymetrix Inc

        • 11.5.1 Affymetrix Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Affymetrix Inc Non-Invasive Cancer Diagnostics Product Profiles, Application and Specification

        • 11.5.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Precision Therapeutics

        • 11.6.1 Precision Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Precision Therapeutics Non-Invasive Cancer Diagnostics Product Profiles, Application and Specification

        • 11.6.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Gen-Probe Inc

        • 11.7.1 Gen-Probe Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Gen-Probe Inc Non-Invasive Cancer Diagnostics Product Profiles, Application and Specification

        • 11.7.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Digene Corporation

        • 11.8.1 Digene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Digene Corporation Non-Invasive Cancer Diagnostics Product Profiles, Application and Specification

        • 11.8.3 Digene Corporation Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 AVIVA Biosciences Corporation

        • 11.9.1 AVIVA Biosciences Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product Profiles, Application and Specification

        • 11.9.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 A&G Pharmaceutical

        • 11.10.1 A&G Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Product Profiles, Application and Specification

        • 11.10.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Non-Invasive Cancer Diagnostics Industry Investment Prospect and Risk Assessment

    • 12.1 Non-Invasive Cancer Diagnostics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Non-Invasive Cancer Diagnostics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure China Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Non-Invasive Cancer Diagnostics Production Value and Growth Rate (2017-2028)

    • Figure China Non-Invasive Cancer Diagnostics Production Value and Growth Rate (2017-2028)

    • Figure Global Non-Invasive Cancer Diagnostics Market Size and Growth Rate of CTCs (2017-2028)

    • Figure Global Non-Invasive Cancer Diagnostics Market Size and Growth Rate of CTNAS (2017-2028)

    • Figure Global Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Exosomes (2017-2028)

    • Figure Global Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Blood (2017-2028)

    • Figure Global Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Urine (2017-2028)

    • Figure Global Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Saliva (2017-2028)

    • Figure North America Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Non-Invasive Cancer Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Non-Invasive Cancer Diagnostics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Non-Invasive Cancer Diagnostics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Non-Invasive Cancer Diagnostics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Non-Invasive Cancer Diagnostics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Non-Invasive Cancer Diagnostics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Non-Invasive Cancer Diagnostics Market Share, by Manufacturer in 2021

    • Figure Global and China Non-Invasive Cancer Diagnostics Market Share, by Manufacturer in 2022

    • Table Global Non-Invasive Cancer Diagnostics Sales Volume, by Type (2017-2028)

    • Table Global Non-Invasive Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure Global Non-Invasive Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table Global Non-Invasive Cancer Diagnostics Sales Value, by Type (2017-2028)

    • Table Global Non-Invasive Cancer Diagnostics Sales Value Share, by Type (2017-2028)

    • Figure Global Non-Invasive Cancer Diagnostics Price Trend, by Type (2017-2028)

    • Table China Non-Invasive Cancer Diagnostics Sales Volume, by Type (2017-2028)

    • Table China Non-Invasive Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure China Non-Invasive Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table China Non-Invasive Cancer Diagnostics Sales Value, by Type (2017-2028)

    • Table China Non-Invasive Cancer Diagnostics Sales Value Share, by Type (2017-2028)

    • Figure China Non-Invasive Cancer Diagnostics Price Trend, by Type (2017-2028)

    • Table Global Non-Invasive Cancer Diagnostics Sales Volume, by Application (2017-2028)

    • Table Global Non-Invasive Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Global Non-Invasive Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Table Global Non-Invasive Cancer Diagnostics Sales Value, by Application (2017-2028)

    • Table Global Non-Invasive Cancer Diagnostics Sales Value Share, by Application (2017-2028)

    • Figure Global Non-Invasive Cancer Diagnostics Sales Value Share, by Application (2017-2028)

    • Table China Non-Invasive Cancer Diagnostics Sales Volume, by Application (2017-2028)

    • Table China Non-Invasive Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure China Non-Invasive Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Table China Non-Invasive Cancer Diagnostics Sales Value, by Application (2017-2028)

    • Table China Non-Invasive Cancer Diagnostics Sales Value Share, by Application (2017-2028)

    • Figure China Non-Invasive Cancer Diagnostics Sales Value Share, by Application (2017-2028)

    • Figure China Non-Invasive Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Non-Invasive Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Non-Invasive Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Non-Invasive Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Non-Invasive Cancer Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Table North America Non-Invasive Cancer Diagnostics Sales Volume, by Type (2017-2028)

    • Table North America Non-Invasive Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure North America Non-Invasive Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table North America Non-Invasive Cancer Diagnostics Sales Volume, by Application (2017-2028)

    • Table North America Non-Invasive Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure North America Non-Invasive Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure United States Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table Europe Non-Invasive Cancer Diagnostics Sales Volume, by Type (2017-2028)

    • Table Europe Non-Invasive Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Non-Invasive Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table Europe Non-Invasive Cancer Diagnostics Sales Volume, by Application (2017-2028)

    • Table Europe Non-Invasive Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Non-Invasive Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure UK Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure France Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure France Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table APAC Non-Invasive Cancer Diagnostics Sales Volume, by Type (2017-2028)

    • Table APAC Non-Invasive Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Non-Invasive Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table APAC Non-Invasive Cancer Diagnostics Sales Volume, by Application (2017-2028)

    • Table APAC Non-Invasive Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Non-Invasive Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure China Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure China Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure India Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure India Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Non-Invasive Cancer Diagnostics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Non-Invasive Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Non-Invasive Cancer Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Non-Invasive Cancer Diagnostics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Non-Invasive Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Non-Invasive Cancer Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Non-Invasive Cancer Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Non-Invasive Cancer Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table Cancer, Genetics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cancer, Genetics Inc Product Profiles, Application and Specification

    • Table Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BIOVIEW Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BIOVIEW Inc Product Profiles, Application and Specification

    • Table BIOVIEW Inc Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Quest Diagnostics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Quest Diagnostics Inc Product Profiles, Application and Specification

    • Table Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Laboratory Corporation of America Holdings (LabCorp) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Laboratory Corporation of America Holdings (LabCorp) Product Profiles, Application and Specification

    • Table Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Affymetrix Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Affymetrix Inc Product Profiles, Application and Specification

    • Table Affymetrix Inc Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Precision Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Precision Therapeutics Product Profiles, Application and Specification

    • Table Precision Therapeutics Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gen-Probe Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gen-Probe Inc Product Profiles, Application and Specification

    • Table Gen-Probe Inc Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Digene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Digene Corporation Product Profiles, Application and Specification

    • Table Digene Corporation Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AVIVA Biosciences Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AVIVA Biosciences Corporation Product Profiles, Application and Specification

    • Table AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table A&G Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table A&G Pharmaceutical Product Profiles, Application and Specification

    • Table A&G Pharmaceutical Non-Invasive Cancer Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US